Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple Sclerosis
Generic interferon-beta
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
2-chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.
Physicians from Accentia and Johns Hopkins University present plans for new MS drug study for Cyrevia
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.
GeNeuro Successful Phase 2a Clinical Study Reinforces Novel Approach to Treat Multiple Sclerosis: Patients Receiving First in Class GNbAC1 Mab Are Stable After One Year
Treatment satisfaction, adherence and behavioral assessment in patients de - escalating from natalizumab to interferon beta.
The Inaugural Hillel Panitch, MD Multiple Sclerosis Symposium
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.
Genmab announces positive top-line Phase II results of ofatumumab in multiple sclerosis
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis.
ALSUntangled No. 8: Low dose naltrexone for ALS.
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab.
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
Thrombotic microangiopathy associated with interferon beta.
Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy
Biogen Idec's long-acting beta interferon moves ahead in MS
Biogen Reports Another Tecfidera PML Case
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE.

Pages